hereditary cancer
FDA Grants Marketing Authorization for Invitae Hereditary Cancer DNA Sequencing Test
The Invitae Common Hereditary Cancers Panel is the first test of its kind to obtain FDA marketing authorization, creating an easier pathway for similar tests.
The company, infamous and long derided in the genetic testing community for refusing to share BRCA1/2 variants, has decided to change its stance as part of a "strategic transformation."
Genome Medical, Hereditary Neuropathy Foundation Partner for Charcot-Marie-Tooth Disease Testing
The CMT Genie Project aims to provide faster and more equitable access to genetic testing for the CMT community via virtual services.
Myriad Genetics Q1 Product Revenues Increase 3 Percent
The company reported revenues of $164.9 million, all of which came from its molecular testing business, beating analysts' consensus expectation.
Senate Bill Proposes to Expand Medicare Coverage for Hereditary Cancer Testing
Legislators sponsoring the bill hope the move will improve access to cancer screenings, preventative surgeries, and save lives.